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Flow and Resistance by Cardiac Magnetic
Resonance in Congenital Heart Diseases
With Unrestricted Left-to-Right Shunt
Aaron Bell, MB, CHB,*† Philipp Beerbaum, MD,*† Gerald Greil, MD,*†
Sanjeet Hegde, MBBS,* André Michael Toschke, MD, MSC, MPH,‡
Tobias Schaeffter, PHD,* Reza Razavi, MD*†
London, United Kingdom
O B J E C T I V E S To determine whether noninvasive assessment of pulmonary artery ﬂow (Qp) by
cardiac magnetic resonance (CMR) would predict pulmonary vascular resistance (PVR) in patients with
congenital heart disease characterized by an unrestricted left-to-right shunt.
B A C KG ROUND Patients with an unrestricted left-to-right shunt who are at risk of obstructive
pulmonary vascular disease require PVR evaluation preoperatively. CMR cardiac catheter (XMR)
combines noninvasive measurement of Qp by phase contrast imaging with invasive pressure measure-
ment to accurately determine the PVR.
METHOD S Patients referred for clinical assessment of the PVR were included. The XMR was used to
determine the PVR. The noninvasive parameters, Qp and left-to-right shunt (Qp/Qs), were compared
with the PVR using univariate regression models.
R E S U L T S The XMR was undertaken in 26 patients (median age 0.87 years)—ventricular septal defect
46.2%, atrioventricular septal defect 42.3%. Mean aortic ﬂow was 2.24  0.59 l/min/m2, and mean Qp
was 6.25  2.78 l/min/m2. Mean Qp/Qs was 2.77  1.02. Mean pulmonary artery pressure was 34.8 
10.9 mm Hg. Mean/median PVR was 5.5/3.0 Woods Units (WU)/m2 (range 1.7 to 31.4 WU/m2). The PVR
was related to both Qp and Qp/Qs in an inverse exponential fashion by the univariate regression
equations PVR  exp(2.53  0.20[Qp]) and PVR  exp(2.75  0.52[Qp/Qs]). Receiver-operator
characteristic (ROC) analysis was used to determine cutoff values for Qp and Qp/Qs above which the PVR
could be regarded as clinically acceptable. A Qp of6.05 l/min/m2 predicted a PVR of3.5 WU/m2 with
sensitivity 72%, speciﬁcity 100%, and area under the ROC curve 0.90 (p  0.002). A Qp/Qs of 2.5/1
predicted a PVR of 3.5 WU/m2 with sensitivity 83%, speciﬁcity 100%, and area under the curve ROC
0.94 (p  0.001).
CONC L U S I O N S Measurement of Qp or left-to-right shunt noninvasively by CMR has potential to
predict the PVR in patients with an unrestricted left-to-right shunt and could potentially determine
operability without having to undertake invasive testing. (J Am Coll Cardiol Img 2009;2:1285–91)
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1286epair of congenital heart disease resulting in
significant left-to-right shunt, such as ven-
tricular septal defect, is usually undertaken in
infancy to prevent progressive pulmonary
ascular disease (1,2). However, some will present
t an advanced age (3) or have other comorbidity
e.g., lung disease of prematurity) predisposing
hem to pulmonary vascular disease (4,5). This
esults in increased perioperative mortality, and
epair might be contra-indicated (6,7).
The oximetric (Fick) method of assessing pulmo-
ary vascular resistance (PVR) is limited at high
ow rates and oxygen saturations (8–10). We have
reviously shown that, by combining phase contrast
ardiac magnetic resonance (CMR) (11)—which
precisely quantifies blood flow patients
with congenital heart disease (12)—with
simultaneous invasive pressure measure-
ments in a combined X-ray and CMR
cardiac catheterization laboratory (XMR),
PVR can be precisely determined, over-
coming the limitations of the oximetric
method. Additionally, this method elimi-
nates the need to measure oxygen con-
sumption and reduces radiation dose
(13,14). The XMR is now our standard
technique for PVR assessment in patients
with congenital heart disease.
The PVR can be described by: PVR 
trans-pulmonary gradient (TPG)/flow. In
an unrestrictive cardiac defect, an inverse
exponential relationship between pulmo-
nary blood flow and PVR is expected (1).
With the XMR technique, we hypothesize
that PVR can be estimated from the de-
gree of pulmonary blood flow or shunt
magnitude. This might allow us to predict
noninvasively whether PVR is within an
acceptable range to proceed to surgery,
voiding catheterization. We tested this prospec-
ively in children and adults with congenital heart
isease who had been referred for PVR assessment.
E T H O D S
tudy population. Patients of all ages with con-
enital heart disease with a potentially unre-
tricted left-to-right shunt that had been referred
or PVR assessment were included. Excluded
ere those with mechanical pulmonary obstruc-
ion (pulmonary artery band or bilateral branch
tenosis), arrhythmia, and CMR contraindica-
rtery
ary
tio)
c
ient
diacion. The local ethics committee approved the study Bnd clinical use of the XMR for the assessment of
VR in adults and children. Informed consent was
btained from all patients or the parents/legal guard-
ans of those under 16 years.
MR catheterization. The CMR catheterization
as performed as a single procedure in an XMR
uite with a 1.5-T Achieva MRI Scanner and a
ingle plane Pulsera Cardiac X-Ray Unit (Philips
ealthcare, Best, the Netherlands). Procedures
ere undertaken with general anesthesia and
entilation to normocarbia in 30% oxygen to
vercome the potential effects of atelectasis (15).
ressures were measured (right atrial, left atrial or
ulmonary artery wedge, pulmonary artery and
ystemic arterial pressures) with multipurpose
atheters (Cordis Corporation, Miami, Florida)
anipulated under fluoroscopic guidance. These
ere exchanged for nonbraided balloon-tipped
ngiographic catheters, which remain in situ for
MR scanning without risk of heating. Patients
ere transferred into the CMR scanner via an
nterconnecting table. Pulmonary artery and aor-
ic phase contrast CMR flows were obtained from
ross-sectional imaging planes with a free-
reathing flow-sensitive segmented k-space fast
eld echo sequence (approximate echo time 3 ms,
pproximate repetition time 5 ms, matrix 128 
56, field of view 250 to 350 mm, flip angle 15°,
umber of signal averages 3, retrospective gating,
0 phases). In patients with an arterial duct,
ulmonary flow (Qp) was the sum of left and
ight branch flow. Simultaneous pressures were
etermined with the average of 5 consecutive
ardiac cycles at the start of each flow sequence.
VR and shunt assessment. Viewforum software
version 4.1, Philips Healthcare) with a semiau-
omatic border detection algorithm with manual
orrection was used to determine the stroke
olume and cardiac output. The PVR was calcu-
ated by dividing the mean trans-pulmonary
radient (MTPG) by indexed Qp. Systemic vas-
ular resistance was calculated with correspond-
ng systemic parameters. Pulmonary to systemic
esistance (Rp/Rs) and flow (Qp/Qs) ratios were
alculated.
tatistical analysis. Continuous data are expressed as
ean (SD). Pearson correlation coefficient was used
o compare measures of pulmonary resistance. Gen-
ralized linear models were used to assess the relation-
hip between PVR and Qp/Qs, Qp, mean pulmonary
rtery pressure (MPAP), and MTPG. We used the
kaike information criterion (AIC) and the SchwarzB B R E V I A T I O N S
N D A C R O N YM S
I confidence interval
MR cardiac magnetic
esonance
PAPmean pulmonary a
ressure
TPGmean trans-pulmon
radient
VR pulmonary vascular
esistance
p pulmonary flow
s aortic flow
p/Qs left-to-right shunt
pulmonary/systemic flow ra
OC receiver-operator
haracteristic
p/Rs pulmonary/systemi
esistance ratio
PG trans-pulmonary grad
MR combined cardiac
agnetic resonance and carayesian information criterion (BIC) to compare
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1287inear (identity link) models with exponential models
log link). A statistical model is considered better-
tting if its AIC is smaller than the AIC of another.
e calculated 95% confidence intervals (CIs) for the
orresponding regression curves. Receiver-operator
haracteristic (ROC) analysis was used to determine
utoff values with sensitivity and specificity. The Stu-
ent t test was used for the comparison between
atients with and without Down syndrome. All sta-
istical analyses were carried out with the statistical
oftware packages SPSS (version 14.0, SPSS, Inc.,
Table 1. Case Summary Illustrating Demographic Data, Diagnos
Patient
#
Age
(yrs)
BSA
(m2) Diagnosis
1 1.8 0.46 AVSD
Previous repair, residual VSD
2 35.2 1.40 AVSD
3 0.9 0.41 Peri-membranous VSD
4 42.4 1.47 VSD, ASD
Restrictive lung disease
5 0.5 0.35 AVSD
6 0.8 0.30 VSD
7 1.1 0.42 AVSD
8 0.3 0.32 AVSD, oxygen dependency
9 0.8 0.39 AVSD
10 2.5 0.52 AVSD
11 0.5 0.28 AVSD, oxygen dependency
12 0.3 0.22 VSD
Congenital diaphragmatic
hernia, oxygen dependency
13 0.7 0.34 Residual ascending vein after
repair of TAPVC
14 0.8 0.30 AVSD, large residual VSD after
repair
15 17.3 1.33 Large patent arterial duct
16 15.9 1.25 Double inlet left ventricle with
malposed great arteries; no
previous procedures
17 1.8 0.52 Peri-membranous VSD
Previous coarctation repair
18 4.0 0.60 Multiple muscular VSDs
19 0.9 0.40 Peri-membranous VSD
20 3.9 0.65 AVSD repair
Residual primum ASD
21 1.8 0.45 Peri-membranous VSD
22 0.3 0.23 AVSD, airway compression,
oxygen dependency
23 0.4 0.28 Peri-membranous VSD
Pulmonary hypertension
without heart failure
24 0.4 0.30 Peri-membranous VSD, oxygen
dependency
25 2.2 0.45 Peri-membranous VSD
26 21.8 2.08 Large multiple VSDs
*Right atrial pressure not recorded.
ASD  atrial septal defect; AVSD  atrioventricular septal defect; BSA  bod
resistance; Qp/Qs  left-to-right shunt; Rp/Rs  pulmonary to systemic resista
ventricular septal defect.hicago, Illinois) and R version 2.6.016 (R Founda-
ion for Statistical Computing, Vienna, Austria). The
uthors had full access to the data and take responsi-
ility for its integrity.
E S U L T S
emographic data. Between 2002 and 2007, 34
atients met the inclusion criteria; 8 were ex-
luded (7 with pulmonary artery band, 1 with
ranch pulmonary stenosis), leaving 26 patients
nd Physiological Variables
isomy
21
MPAP
(mm Hg)
TPG
(mm Hg)
PA Flow
(l/min/m2)
PVR
(WU/m2)
Yes 46 27 5.85 4.6
No 18 9 8.60 1.7
No 45 19 8.05 2.3
No 26 14 4.80 2.9
Yes 31 21 6.30 3.3
No 34 21 10.00 2.1
Yes 43 38 4.40 8.6
Yes 25 20 5.12 3.9
Yes 45 33 2.72 12.0
Yes 46 27 12.90 2.1
Yes 34 22 6.25 3.5
No 35 25 7.50 3.3
No 24 15 5.70 2.6
Yes 30 16 3.93 4.1
Yes 52 42 1.65 25.4
No 35 21 7.00 3.0
No 34 13 6.71 1.9
No 25 15 4.50 3.3
No 31 18 9.40 1.9
Yes 13 8 2.80 2.9
No 40 24 9.64 2.5
No 24 12 4.78 2.5
No 33 25 4.89 5.1
Yes 32 21 7.42 2.8
No 41 24 10.10 2.4
No 62 48 1.53 31.4
rface area; MPAP  mean pulmonary artery pressure; PA  pulmonary artery; P
ratio; TAPVC  total anomalous pulmonary venous connection; TPG  trans-puis, a
Tr
Rp/Rs Qp/Qs
0.24 2.3
* 4.0
0.12 3.2
0.17 2.0
0.19 3.7
0.14 2.7
0.36 2.0
0.26 2.1
0.73 1.3
0.16 3.7
0.21 3.2
0.14 4.6
0.12 3.0
0.32 1.8
0.95 1.1
0.12 4.4
0.12 2.4
0.16 3.0
0.14 3.3
0.12 1.8
0.14 3.4
0.11 2.8
0.38 2.1
0.20 4.1
0.13 3.4
1.54 0.7
y su VR  pulmonary vascular
nce lmonary gradient; VSD 
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1288ncluded in the analysis. The majority were in-
ants and children, median age 0.87 years (range
.25 to 42.4 years). Primary diagnosis was ven-
ricular septal defect in 12 patients (46.2%) and
trioventricular septal defect in 11 (42%). Eleven
42%) had Down syndrome. Demographic and
hysiological parameters are detailed in Table 1.
esistance, ﬂow, and pressure relationships. The
easures of pulmonary resistance, PVR and
p/Rs (0.29  0.07), had a very strong linear
elationship (Pearson’s correlation coefficient 
.98). Therefore resistance is expressed by PVR
lone. The mean physiological findings were:
ortic flow (Qs) 2.24  0.59 l/min/m2, Qp
.25  2.78 l/min/m2, Qp/Qs 2.77  1.02,
PAP 34.8  10.9 mm Hg, and MTPG 22.23 
.6 mm Hg. The mean/median PVR was 5.5/3.0
oods Units (WU)/m2 (range 1.7 to 31.4 WU/m2).
xponential relationships were observed between the
VR and all parameters (Table 2)—Qp/Qs and Qp,
nversely; MPAP and MTPG, directly. Regression
urves with CIs are described for Qp (Fig. 1A) and
p/Qs (Fig. 1B). From these we calculated univar-
ate prediction formulae of: PVR  exp(2.53 
.20[Qp]) and PVR  exp(2.75  0.52[Qp/Qs]).
Regression curves can also be described for the
PAP and MTPG (Fig. 2); however, the scatter
f data and CIs are much wider. A Qp/Qs in
xcess of 2/1 is considered to be an indication for
urgical intervention (16). In our patient group,
he maximum PVR in patients with a shunt in
xcess of this (i.e., Qp/Qs  2.5/1) was 3.5
U/m2. Because the normal range for PVR (17)
s 1.0 to 3.0 WU/m2, a cutoff value of 3.5 WU/m2
eemed clinically reasonable. A ROC analysis was
sed to determine preliminary cutoff values for
ow and shunt to estimate the PVR of 3.5
U/m2. A Qp/Qs  2.5/1 determined those
ith a PVR of 3.5 WU/m2 with sensitivity 83%
of Predictors of PVR by Identity (Linear) and Log
(Link) AIC BIC Linear Predictor p Value
166 170 18.25  4.61(Qp/Qs) 0.001
45 49 exp(2.75  0.52[Qp/Qs]) 0.001
169 172 15.34  1.58(Qp) 0.001
43 47 exp(2.53  0.20[Qp]) 0.001
165 169 9.95  0.44(MPAP) 0.001
50 53 exp(0.21  0.04[MPAP]) 0.001
152.5 156.2 8.05  0.61(TPG) 0.001
30.7 34.5 exp(0.14  0.065[TPG]) 0.001
n criterion; BIC  Schwarz Bayesian information criterion; MTPG  mean1Qp  indexed pulmonary blood ﬂow; other abbreviations as in Table 1.95% CI: 64% to 98%), specificity 100% (95% CI:
0% to 100%), and positive predictive value
PPV) 62% (95% CI: 41% to 97%), and area
nder the ROC curve 0.94 (p  0.001) (Figs. 3A
nd 3B). A Qp 6.05 l/min/m2 determined
hose with a PVR of 3.5 WU/m2 with sensi-
ivity 78% (95% CI: 52% to 93%), specificity
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Figure 1. Relationship Between Resistance and
Flow Parameters
Univariate regression models with 95% conﬁdence intervals (CIs)
are shown demonstrating the inverse exponential relationship
between pulmonary vascular resistance (PVR) and (A) pulmonary
artery ﬂow (Qp) and (B) left-to-right shunt. Given the patient
numbers, the CIs are quite wide; however, all patients with an
elevated Qp or shunt in excess of 2.5/1 have a PVR 3.5 Woods
Units (WU)/m2. Of note, only a small number of patients had an
elevated PVR.Table 2. Comparison
(Exponential) Links
Explanatory Variable
QP/QS (identity)
QP/QS (log)
Qpi (identity)
Qpi (log)
MPAP (identity)
MPAP (log)
MTPG (identity)
MTPG (log)
AIC  Akaike informatio00% (95% CI: 60% to 100%), and PPV 54%
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128995% CI: 34% to 74%), with the area under the
OC curve 0.90 (p  0.002) (Figs. 3C and 3D).
To test the cutoff values derived from the ROC
nalysis, they were applied to the regression
Regression Curve              95% Confidence Limits
PV
R
 (W
U.
m2
)
PV
R
 (W
U.
m2
)
Mean Pulmonary Artery Pressure (mm Hg)
0
5
10
15
20
25
30
35
20 30 5040 60
Mean Transpulmonary Gradient (mm Hg)
0
5
10
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20
25
30
35
10 20 4030 50
A
B
Figure 2. Relationship Between Resistance and
Pressure Parameters
Univariate regression models with 95% CIs are shown demon-
strating the direct exponential relationship between PVR and
(A) mean pulmonary artery pressure (MPAP) (mm Hg) and
(B) the mean transpulmonary gradient. The CIs for MPAP are
very wide, and the MPAP can be in excess of 40 mm Hg with
the PVR remaining within an acceptable range. This illustrates
that pulmonary artery pressure measurements alone provide an
incomplete picture, and clinical decisions should not be based
on pressure parameters alone. Abbreviations as in Figure 1.quations. The Qp performed well; a flow of 6.05 f/min/m2 would predict a PVR of 3.59 WU/m2.
eft-to-right shunt performs less well, with a
hunt of 2.5/1 predicting a PVR of 3.94 WU/m2.
ith the same formula, a shunt of 2.8/1 would
redict a PVR of 3.5 WU/m2.
own syndrome. Data for patients with and with-
ut Down syndrome are shown in Table 3. No
ifference in any of the physiological parameters
as detected.
I S C U S S I O N
his study focuses on the small but important
roup of patients with a large left-to-right shunt
ith potentially elevated PVR. The CMR cath-
ter gives us a unique opportunity to examine the
elationship between PVR and a noninvasive
easure of flow in these patients.
elationship of PVR to ﬂow and pressure. The PVR
s determined by dividing the MTPG by Qp;
herefore, PVR would be expected to be directly
elated to pressure and inversely related to flow in
n exponential fashion. We were able to demon-
trate this and generate univariate regression
quations that were most powerful when based on
ow followed by shunt. In contrast, MPAP was
ound to give a poor estimate of PVR with a wide
catter. Importantly, there were patients with a
ormal PVR who had an MPAP in excess of 40
m Hg, indicating that indirect estimates of
ulmonary artery pressure, although demonstrat-
ng pulmonary hypertension, might not accu-
ately reflect the PVR.
Patients with Down syndrome and atrioven-
ricular septal defect have been shown to be at
reater risk of developing pulmonary vascular
isease. This has been demonstrated in children
1 year of age, and early repair is recommended
18,19). We did not demonstrate any difference
n the PVR of patients with or without Down
yndrome and atrioventricular septal defect. This
s likely to be a reflection of the sample size and
he study population, because those who clearly
ave Eisenmengers syndrome are not referred for
reoperative evaluation. There were 7 patients
ver 1 year old, including patients ages 15, 35,
nd 42 years. All had a PVR that would make
hem amenable for surgery. This suggests that,
hen considering patients with chronically ele-
ated pulmonary blood flow, even with Down
yndrome, a diagnosis of pulmonary vascular
isease and inoperability cannot be assumed, and
urther investigation might be warranted.
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1290an we now estimate PVR from Qp? In our group
nly 4 patients had a PVR 6 WU/m2. We
annot draw conclusions when PVR is elevated,
ut consideration of the predictive value of Qp
ight be justified in the group where PVR is
orderline or normal. We found that we could
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Figure 3. Cutoff Values for PVR
Scatterplot and corresponding receiver-operator characteristic (ROC
Qp (C, D). All patients with a PVR 3.5 WU/m2 had a Qp/Qs 2.5/1
area under the ROC curve of 0.90. With future validation these valu
l/min/m2 or a shunt 2.5/1 measured by phase contrast cardiac ma
ment. Abbreviations as in Figure 1.
Table 3. Comparison of Parameters for Down Syndrome
Demonstrating Mean (SD) and Probability Value
Parameters
Down Syndrome
Present Not Present p Value
n 11 15 —
Age (yrs)* 0.83 (0.33–16.97) 1.75 (0.25–42.18) 0.19
BSA (m2) 0.48 (0.30) 0.69 (0.57) 0.24
MPAP (mm Hg) 36.1 (11.5) 33.8 (10.7) 0.61
MTPG (mm Hg) 25.0 (9.2) 20.2 (9.8) 0.22
Qp (l/min/m2) 5.39 (3.05) 6.88 (2.50) 0.19
Qp/Qs 2.46 (1.04) 3.00 (0.98) 0.19
PVR (WU/m2) 6.65 (6.88) 4.60 (7.46) 0.48
Rp/Rs 0.34 (0.27) 0.25 (0.38) 0.52
*Median (range).aAbbreviations as in Tables 1 and 2.stimate a PVR of 3.5 WU/m2 if Qp was
6.05 l/min/m2 or if Qp/Qs was 2.5/1 with
igh sensitivity. These figures do need to be
iewed with caution, given the sample size, and
his is reflected within the confidence limits;
owever, it does suggest that with further large
tudies a more robust model of PVR in this
etting might be achievable.
tudy limitations. Patients with an unrestrictive ven-
ricular or atrioventricular septal defect not repaired
t the appropriate time are rare in the developed
orld, significantly limiting the number of patients
e are able to include in this study and additionally
imiting the conclusions that can be drawn from the
tatistical analysis. Because the majority had a
orderline or normal PVR, we cannot comment on
hose with elevated PVR.
O N C L U S I O N S
ur study describes the exponential relationship
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uggested preliminary regression equations with
hich the PVR can be estimated from noninvasive
p measurements alone, and these seem reasonable
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ver, further studies are needed to validate this,
specially with elevated PVR. Our results holdof patients with ventricular septal de- simiavona R, et al.perability of patients with an unrestrictive cardiac
efect might be able to be performed by PC-CMR
ow alone.
eprint requests and correspondence: Dr. Aaron Bell, De-
artment of Paediatric Cardiology, Evelina Children’s
ospital, Guy’s and St. Thomas NHS Foundation Trust,
Westminster Bridge Road, London SE1 7EH, Unitedromise that, in future, prediction of PVR and the Kingdom. E-mail: Aaron.Bell@gstt.nhs.uk.1
1
1
1
1
K
r
d
pE F E R E N C E S
1. McDaniel NL, Gutgesell HP. Ven-
tricular septal defects. In: Allen HD,
Clark EB, Gutgesell HP, Driscoll AJ,
editors. Moss and Adams’ Heart Dis-
ease in Infants, Children and Adoles-
cents Including the Fetus and Young
Adult. Philadelphia, PA: Lippincott
Williams and Wilkins, 2001:636–51.
2. Yamaki S, Yasui H, Kado H, et al.
Pulmonary vascular disease and oper-
ative indications in complete atrioven-
tricular canal defect in early infancy.
J Thorac Cardiovasc Surg 1993;106:
398–405.
3. Massin MM, Dessy H. Delayed rec-
ognition of congenital heart disease.
Postgrad Med J 2006;82:468–70.
4. Cohen MS, Rychik J, Bush DM, et al.
Influence of congenital heart disease
on survival in children with congenital
diaphragmatic hernia. J Pediatr 2002;
141:25–30.
5. Kumar VH, Hutchison AA, Laksh-
minrusimha S, Morin FC III, Wynn
RJ, Ryan RM. Characteristics of pul-
monary hypertension in preterm neo-
nates. J Perinatol 2007;27:214–9.
6. Friedli B, Langford Kidd BS, Mus-
tard WT, Keith JD. Ventricular septal
defect with increased pulmonary vas-
cular resistance: late results of surgical
closure. Am J Cardiol 1974;33:403–9.
7. Neutze JM, Ishikawa T, Clarkson
PM, Calder AL, Barratt-Boyes BG,
Kerr AR. Assessment and follow-upfect and elevated pulmonary vascular
resistance. Am J Cardiol 1989;63:
327–31.
8. Cigarroa RG, Lange RA, Hillis LD.
Oximetric quantitation of intracardiac
left-to-right shunting: limitations of
the Qp/Qs ratio. Am J Cardiol 1989;
64:246–7.
9. Hillis LD, Firth BG, Winniford MD.
Analysis of factors affecting the vari-
ability of fick versus indicator dilution
measurements of cardiac output. Am J
Cardiol 1985;56:764–8.
10. Dhingra VK, Fenwick JC, Walley
KR, Chittock DR, Ronco JJ. Lack of
agreement between thermodilution
and fick cardiac output in critically ill
patients. Chest 2002;122:990–7.
11. Firmin DN, Nayler GL, Klipstein
RH, Underwood SR, Rees RS, Long-
more DB. In vivo validation of MR
velocity imaging. J Comput Assist
Tomogr 1987;11:751–6.
12. Beerbaum P, Korperich H, Barth P,
Esdorn H, Gieseke J, Meyer H. Non-
invasive quantification of left-to-right
shunt in pediatric patients: phase-
contrast cine magnetic resonance im-
aging compared with invasive oxime-
try. Circulation 2001;103:2476–82.
13. Razavi R, Hill DL, Keevil SF, et al
Cardiac catheterisation guided by
MRI in children and adults with con-
genital heart disease. Lancet 2003;
362:1877–82.
14. Muthurangu V, Taylor A, Andriant-
Novel method of squantifying pulmonary vascular resis-
tance by use of simultaneous invasive
pressure monitoring and phase-contrast
magnetic resonance flow. Circulation
2004;110:826–34.
5. Hedenstierna G. Alveolar collapse
and closure of airways: regular effects
of anaesthesia. Clin Physiol Funct Im-
aging 2003;23:123–9.
6. Kidd L, Driscoll DJ, Gersony, et al.
Second natural history study of con-
genital heart defects. Results of treat-
ment of patients with ventricular sep-
tal defects. Circulation 1993;87 Suppl:
I38–51.
7. Park MK. Pediatric Cardiology for
Practitioners. St Louis, MO: Mosby,
2002:83–9.
8. Clapp S, Perry BL, Farooki ZQ, et al.
Down’s syndrome, complete atrioven-
tricular canal, and pulmonary vascular
obstructive disease. J Thorac Cardio-
vasc Surg 1990;100:115–21.
9. Hals J, Hagemo PS, Thaulow E, Sor-
land SJ. Pulmonary vascular resistance
in complete atrioventricular septal de-
fect. A comparison between children
with and without Down’s syndrome.
Acta Paediatr 1993;82:595–8.
ey Words: cardiac magnetic
esonance y congenital y heart
efects y pediatrics y
ulmonary vascular resistance y
hunts.
